ECSP034653A - GIRASA INHIBITORS AND USES OF THE SAME - Google Patents

GIRASA INHIBITORS AND USES OF THE SAME

Info

Publication number
ECSP034653A
ECSP034653A EC2003004653A ECSP034653A ECSP034653A EC SP034653 A ECSP034653 A EC SP034653A EC 2003004653 A EC2003004653 A EC 2003004653A EC SP034653 A ECSP034653 A EC SP034653A EC SP034653 A ECSP034653 A EC SP034653A
Authority
EC
Ecuador
Prior art keywords
inhibitors
relates
girasa
same
compounds
Prior art date
Application number
EC2003004653A
Other languages
Spanish (es)
Inventor
Anne-Laure Grillot
Paul Charifson
Yusheng Liao
Michael Badia
Martin Trudeau
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ECSP034653A publication Critical patent/ECSP034653A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a compuestos de la formula I o un derivado farmacéuticamente aceptable o prodroga del mismo. Los compuestos son útiles como inhibidores de actividad de girasas bacterianas. La presente invención también se refiere a métodos de tratamiento de infecciones bacterianas en mamíferos. La presente invención también se refiere a métodos por decrecimiento de cantidad bacteriana en una muestra biológica.This invention relates to compounds of the formula I or a pharmaceutically acceptable derivative or prodrug thereof. The compounds are useful as inhibitors of bacterial gyrase activity. The present invention also relates to methods of treating bacterial infections in mammals. The present invention also relates to methods by decreasing bacterial amount in a biological sample.

EC2003004653A 2000-12-15 2003-06-12 GIRASA INHIBITORS AND USES OF THE SAME ECSP034653A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25609400P 2000-12-15 2000-12-15

Publications (1)

Publication Number Publication Date
ECSP034653A true ECSP034653A (en) 2003-07-25

Family

ID=33449456

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004653A ECSP034653A (en) 2000-12-15 2003-06-12 GIRASA INHIBITORS AND USES OF THE SAME

Country Status (2)

Country Link
EC (1) ECSP034653A (en)
ZA (1) ZA200303933B (en)

Also Published As

Publication number Publication date
ZA200303933B (en) 2004-05-21

Similar Documents

Publication Publication Date Title
BR0116216A (en) Gyrase inhibitors and their uses
PL374191A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
MXPA05008126A (en) Gyrase inhibitors and uses thereof.
UY29458A1 (en) REPLACED HETEROCICLES AND USES OF THE SAME
ECSP003699A (en) FAB I INHIBITORS
ATE433980T1 (en) GYRASINE INHIBITORS AND THEIR USES
CR6577A (en) TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES
TR200201505T2 (en) Pirazolopyrimidines as therapeutic agents
ATE370139T1 (en) PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA INHIBITORS FOR THE TREATMENT OF CANCER
NO20055421L (en) Quinoline derivatives as phosphodiesterase inhibitors
BRPI0409367A (en) piperidine derivatives renin inhibitors
CY1107747T1 (en) Substituted tetraacyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
PA8478501A1 (en) HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS
ATE307810T1 (en) IMIDAZOLE-2-CARBONIC ACID AMIDE DERIVATIVES AS RAF-KINASE INHIBITORS
DE602004020070D1 (en) THIENOPYRIMIDINE DERIVATIVES AS KALIUM CHANNEL INHIBITORS
ATE433963T1 (en) FAB-I INHIBITORS
ATE509018T1 (en) BISINDOLPYRROLES SUITABLE AS ANTIMICROBIAL AGENT
UY30014A1 (en) SUB-GROUP OF OXABISPIDINE-BASED COMPOUNDS UNDERSTANDING A REPLACED AMIDAS RENTAL GROUP, PREPARATION PROCESS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS
AR064152A1 (en) ANTIBACTERIAL QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PREPARATION METHOD.
ATE335739T1 (en) CAK INHIBITORS AND THEIR USES
UY29012A1 (en) "OXAZOLIDIDONS AND RELATED COMPOSITIONS AND METHODS"
SE0004101D0 (en) New use
ES2182035T3 (en) DERIVATIVES OF BISARILCICLOBUTENO AS CICLOOXIGENASA INHIBITORS
ATE419242T1 (en) PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS
ECSP034653A (en) GIRASA INHIBITORS AND USES OF THE SAME